UK regulator approves Astellas' gastric cancer drug
14/08/2024 11:57
Aug 14 (Reuters) - Britain's health regulator said on Wednesday it has approved Astellas Pharma's 4503.T drug to treat a type of gastric cancer. (Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn